title: The brain, amphotericin B, and P-glycoprotein.
authors: Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA California Institute for Medical Research, San Jose, California, USA stevens@stanford.edu.
authors: David A
authors: DA
authors: Stevens
authors: Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA California Institute for Medical Research, San Jose, California, USA.
authors: Karl V
authors: KV
authors: Clemons
authors: California Institute for Medical Research, San Jose, California, USA.
authors: Marife
authors: M
authors: Martinez
authors: California Institute for Medical Research, San Jose, California, USA.
authors: Vicky
authors: V
authors: Chen
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000037:antagonists & inhibitors*; D000666:Amphotericin B / Q000493:pharmacokinetics*; D000818:Animals; D000935:Antifungal Agents / Q000493:pharmacokinetics*; D001812:Blood-Brain Barrier / Q000187:drug effects*; D003453:Cryptococcosis / Q000188:drug therapy*; D008297:Male; D014700:Verapamil / Q000494:pharmacology*
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000935:Antifungal Agents; D000666:Amphotericin B; D014700:Verapamil
references: Antimicrob Agents Chemother. 2014 Aug;58(8):4464-9
references: 24867970